A Peptidyl Inhibitor that Blocks Calcineurin–NFAT Interaction and Prevents Acute Lung Injury

Patrick G.  Dougherty; Manjula  Karpurapu; Amritendu  KoleyJessica K.  LukowskiZiqing  QianTeja  Srinivas NirujogiLuiza  RusuSangwoon  ChungAmanda B.  HummonHao W.  LiJohn W.  ChristmanDehua  Pei

首页> 外文期刊>Journal of Medicinal Chemistry >A Peptidyl Inhibitor that Blocks Calcineurin–NFAT Interaction and Prevents Acute Lung Injury

【24h】

A Peptidyl Inhibitor that Blocks Calcineurin–NFAT Interaction and Prevents Acute Lung Injury

机译：A Peptidyl Inhibitor that Blocks Calcineurin–NFAT Interaction and Prevents Acute Lung Injury

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

Acute respiratory distress syndrome (ARDS) is an inflammatory lung disease with a high morbidity and mortality rate, for which no pharmacologic treatment is currently available. Our previous studies discovered that a pivotal step in the disease process is the activation of the nuclear factor of activated T cells (NFAT) c3 in lung macrophages, suggesting that inhibitors against the upstream protein phosphatase calcineurin should be effective for prevention/treatment of ARDS. Herein, we report the development of a highly potent, cell-permeable, and metabolically stable peptidyl inhibitor, CNI103, which selectively blocks the interaction between calcineurin and NFATc3, through computational and medicinal chemistry. CNI103 specifically inhibited calcineurin signaling in vitro and in vivo and exhibited a favorable pharmacokinetic profile, broad tissue distribution following different routes of administration, and minimal toxicity. Our data indicate that CNI103 is a promising novel treatment for ARDS and other inflammatory diseases.

著录项

来源
《Journal of Medicinal Chemistry》 |2020年第21期|12853-12872|共20页
作者
Patrick G. Dougherty; Manjula Karpurapu; Amritendu KoleyJessica K. LukowskiZiqing QianTeja Srinivas NirujogiLuiza RusuSangwoon ChungAmanda B. HummonHao W. LiJohn W. ChristmanDehua Pei;
展开▼
作者单位

Department of Chemistry and Biochemistry, The Ohio State University;

Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Ohio State University Wexner Medical Center, Davis Heart and Lung Research Institute;

Department of Chemistry and Biochemistry, University of Notre DameColumbia Center for Translational Immunology, Columbia University;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类药学;
关键词

A Peptidyl Inhibitor that Blocks Calcineurin–NFAT Interaction and Prevents Acute Lung Injury

摘要

著录项

相关主题

期刊订阅